Spotlight
Clinical
Blog
Partners
CE
- Therapeutic Cataract & Refractive
- Lens Technology
- Glasses
- Ptosis
- AMD
- COVID-19
- DME
- Ocular Surface Disease
- Optic Relief
- Geographic Atrophy
- Cornea
- Conjunctivitis
- LASIK
- Myopia
- Presbyopia
- Allergy
- Nutrition
- Pediatrics
- Retina
- Cataract
- Contact Lenses
- Lid and Lash
- Dry Eye
- Glaucoma
- Refractive Surgery
- Comanagement
- Blepharitis
- OCT
- Patient Care
- Diabetic Eye Disease
- Technology
Advancements in dry eye managment : Episode 15
Overlapping diseases and COVID-19's impact
EP: 1.Introduction and overview
EP: 2.Consequences and epidemiology of untreated dry eye
EP: 3.Diagnosis and overlooking asymptomatic patients with DED
EP: 4.Standard testing and assessment for DED
EP: 5.General Principles of Treatment of DED
EP: 6.OD and MD communication for optimal care
EP: 7.Review of artificial tears for DED
EP: 8.Corticosteroids and Immunomodulators for the treatment of dry eye
EP: 9.The role of nutritional supplements and antibiotics in DED
EP: 10.How to treat meibomian gland dysfunction
EP: 11.In-office procedures and patient resistance for DED treatments
EP: 12.Treatments for aqueous dry eye
EP: 13.Challenges in the management of DED
EP: 14.Counseling and formulary concerns for DED therapies
Now Viewing
EP: 15.Overlapping diseases and COVID-19's impact
EP: 16.Agents in the pipeline for DED
EP: 17.Novel agents in the pipeline for DED
Related Videos
Related Content
